Complications of the Diabetic Foot

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 4, 2013, Pages 833-847

  Kim, Paul J ^a   Steinberg, John S ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Amputation; Diabetes; Infection; Multidisciplinary; Ulcer; Wound

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

AMPUTATION; BONE MALFORMATION; CALLUS; DEBRIDEMENT; DIABETIC FOOT; GLYCEMIC CONTROL; HUMAN; INFECTION; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SOFT TISSUE DEFECT; ULCER;

AMPUTATION; DIABETES; INFECTION; MULTIDISCIPLINARY; ULCER; WOUND;

AMPUTATION; DEBRIDEMENT; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; RISK FACTORS; SKIN ULCER;

EID: 84888088506     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2013.08.002     Document Type: Review

References (71)

1. Young M.J., Boulton A.J., MacLeod A.F., et al. Amulticentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993, 36:150-154.
2. Kumar S., Ashe H.A., Parnell L.N., et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994, 11:480-484.
3. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998, 41:1263-1269.
4. Sumner C.J., Sheth S., Griffin J.W., et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. NEngl J Med 1993, 329:977-986.
6. Courtemanche R., Teasdale N., Boucher P., et al. Gait problems in diabetic neuropathic patients. Arch Phys Med Rehabil 1996, 77:849-855.
7. Oliveira P.P., Fachin S.M., Tozatti J., et al. Comparative analysis of risk for falls in patients with and without type 2 diabetes mellitus. Rev Assoc Med Bras 2012, 58:234-239.
8. Donahue R.P., Orchard T.J. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 1992, 15:1141-1155.
9. Jude E.B., Oyibo S.O., Chalmers N., et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001, 24:1433-1437.
10. Attinger C.E., Evans K.K., Bulan E., et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg 2006, 117:261S-293S.
11. Marston W.A., Davies S.W., Armstrong B., et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. JVasc Surg 2006, 44:108-114.
12. Jorneskog G., Brismar K., Fagrell B. Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabet Med 1995, 12:36-41.
13. Schramm J.C., Dinh T., Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds 2006, 5:149-159.
14. Jaap A.J., Shore A.C., Stockman A.J., et al. Skin capillary density in subjects with impaired glucose tolerance and patients with type 2 diabetes. Diabet Med 1996, 13:160-164.
15. Boulton A.J., Hardisty C.A., Betts R.P., et al. Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983, 6:26-33.
16. Lavery L.A., Armstrong D.G., Boulton A.J. Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. JAm Podiatr Med Assoc 2002, 92:479-482.
17. Pollard J.P., Le Quesne L.P., Tappin J.W. Forces under the foot. JBiomed Eng 1983, 5:37-40.
18. Delbridge L., Ctercteko G., Fowler C., et al. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 1985, 72:1-6.
19. Brash P.D., Foster J., Vennart W., et al. Magnetic resonance imaging techniques demonstrate soft tissue damage in the diabetic foot. Diabet Med 1999, 16:55-61.
20. Robertson D.D., Mueller M.J., Smith K.E., et al. Structural changes in the forefoot of individuals with diabetes and a prior plantar ulcer. JBone Joint Surg Am 2002, 84:1395-1404.
21. Grant W.P., Sullivan R., Sonenshine D.E., et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. JFoot Ankle Surg 1997, 36:272-278. [discussion: 330].
22. Reddy G.K. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit Achilles tendon. Exp Diabesity Res 2004, 5:143-153.
23. Ledoux W.R., Shofer J.B., Smith D.G., et al. Relationship between foot type, foot deformity, and ulcer occurrence in the high-risk diabetic foot. JRehabil Res Dev 2005, 42:665-672.
24. Lavery L.A. Effectiveness and safety of elective surgical procedures to improve wound healing and reduce re-ulceration in diabetic patients with foot ulcers. Diabetes Metab Res Rev 2012, 28(Suppl 1):60-63.
25. Armstrong D.G., Lavery L.A., Stern S., et al. Is prophylactic diabetic foot surgery dangerous?. JFoot Ankle Surg 1996, 35:585-589.
26. Reiber G.E., Vileikyte L., Boyko E.J., et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157-162.
27. Boyko E.J., Ahroni J.H., Stensel V., et al. Aprospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999, 22:1036-1042.
28. Reiber G.E. The epidemiology of diabetic foot problems. Diabet Med 1996, 13(Suppl 1):S6-11.
29. Hazenberg C.E., van Baal J.G., Manning E., et al. The validity and reliability of diagnosing foot ulcers and pre-ulcerative lesions in diabetes using advanced digital photography. Diabetes Technol Ther 2010, 12:1011-1017.
30. Murray H.J., Young M.J., Hollis S., et al. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996, 13:979-982.
31. Wagner F.W. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981, 2:64-122.
32. Wagner F.W. The diabetic foot. Orthopedics 1987, 10:163-172.
33. Lavery L.A., Armstrong D.G., Harkless L.B. Classification of diabetic foot wounds. JFoot Ankle Surg 1996, 35:528-531.
34. Margolis D.J., Allen-Taylor L., Hoffstad O., et al. Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med 2003, 115:627-631.
35. Sheehan P., Jones P., Giurini J.M., et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg 2006, 117:239S-244S.
36. Hinchliffe R.J., Valk G.D., Apelqvist J., et al. Asystematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008, 24(Suppl 1):S119-S144.
37. Felder J.M., Goyal S.S., Attinger C.E. Asystematic review of skin substitutes for foot ulcers. Plast Reconstr Surg 2012, 130:145-164.
38. Steed D.L., Donohoe D., Webster M.W., et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. JAm Coll Surg 1996, 183:61-64.
39. Attinger C.E., Bulan E.J. Debridement. The key initial first step in wound healing. Foot Ankle Clin 2001, 6:627-660.
40. Armstrong D.G., Liswood P.J., Todd W.F. Potential risks of accommodative padding in the treatment of neuropathic ulcerations. Ostomy Wound Manage 1995, 41:44-46. 48-9.
41. Armstrong D.G., Athanasiou K.A. The edge effect: how and why wounds grow in size and depth. Clin Podiatr Med Surg 1998, 15:105-108.
42. Lavery L.A., Vela S.A., Lavery D.C., et al. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments. Diabetes Care 1996, 19:818-821.
43. Lavery L.A., Vela S.A., Fleischli J.G., et al. Reducing plantar pressure in the neuropathic foot. A comparison of footwear. Diabetes Care 1997, 20:1706-1710.
44. Fleischli J.G., Lavery L.A., Vela S.A., et al. 1997 William J. Stickel Bronze Award. Comparison of strategies for reducing pressure at the site of neuropathic ulcers. JAm Podiatr Med Assoc 1997, 87:466-472.
45. Mueller M.J., Diamond J.E., Sinacore D.R., et al. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 1989, 12:384-388.
46. Armstrong D.G., Nguyen H.C., Lavery L.A., et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001, 24:1019-1022.
47. Mueller M.J., Sinacore D.R., Hastings M.K., et al. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. JBone Joint Surg Am 2003, 85:1436-1445.
48. Parvez N., Dutta P., Ray P., et al. Microbial profile and utility of soft tissue, pus, and bone cultures in diagnosing diabetic foot infections. Diabetes Technol Ther 2012, 14:669-674.
49. Lipsky B.A., Berendt A.R., Cornia P.B., Infectious Diseases Society of America, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:e132-e173.
50. James G.A., Swogger E., Wolcott R., et al. Biofilms in chronic wounds. Wound Repair Regen 2008, 16:37-44.
51. Frank D.N., Wysocki A., Specht-Glick D.D., et al. Microbial diversity in chronic open wounds. Wound Repair Regen 2009, 17:163-172.
52. Dowd S.E., Sun Y., Secor P.R., et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008, 8:43.
53. Stewart P.S., Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358:135-138.
54. Hoiby N., Bjarnsholt T., Givskov M., et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010, 35:322-332.
55. Harrison-Balestra C., Cazzaniga A.L., Davis S.C., et al. Awound-isolated pseudomonas aeruginosa grows a biofilm invitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003, 29:631-635.
56. Kim P.J., Steinberg J.S. Wound care: biofilm and its impact on the latest treatment modalities for ulcerations of the diabetic foot. Semin Vasc Surg 2012, 25:70-74.
57. Trautner C., Haastert B., Giani G., et al. Incidence of lower limb amputations and diabetes. Diabetes Care 1996, 19:1006-1009.
58. Pecoraro R.E., Reiber G.E., Burgess E.M. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990, 13:513-521.
59. Armstrong D.G., Lavery L.A., Quebedeaux T.L., et al. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. JAm Podiatr Med Assoc 1997, 87:321-326.
60. Pinzur M.S., Gold J., Schwartz D., et al. Energy demands for walking in dysvascular amputees as related to the level of amputation. Orthopedics 1992, 15:1033-1036. [discussion: 1036-7].
61. Lee E.T., Russell D., Jorge N., et al. Afollow-up study of diabetic Oklahoma Indians. Mortality and causes of death. Diabetes Care 1993, 16:300-305.
62. Morbach S., Furchert H., Groblinghoff U., et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care 2012, 35:2021-2027.
63. Lavery L.A., Lavery D.C., Quebedeax-Farnham T.L. Increased foot pressures after great toe amputation in diabetes. Diabetes Care 1995, 18:1460-1462.
64. Armstrong D.G., Lavery L.A. Plantar pressures are higher in diabetic patients following partial foot amputation. Ostomy Wound Manage 1998, 44:30-32. 34, 36 passim.
65. Garbalosa J.C., Cavanagh P.R., Wu G., et al. Foot function in diabetic patients after partial amputation. Foot Ankle Int 1996, 17:43-48.
66. Dillon M.P., Barker T.M. Comparison of gait of persons with partial foot amputation wearing prosthesis to matched control group: observational study. JRehabil Res Dev 2008, 45:1317-1334.
67. Kim P.J., Evans K.K., Steinberg J.S., et al. Critical elements to building an effective wound care center. JVasc Surg 2013, 57:1703-1709.
68. Hellingman A.A., Smeets H.J. Efficacy and efficiency of a streamlined multidisciplinary foot ulcer service. JWound Care 2008, 17:541-544.
69. Yesil S., Akinci B., Bayraktar F., et al. Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey. Exp Clin Endocrinol Diabetes 2009, 117:345-349.
70. Faglia E., Favales F., Aldeghi A., et al. Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation. JDiabet Complications 1998, 12:96-102.
71. Chiu C.C., Huang C.L., Weng S.F., et al. Amultidisciplinary diabetic foot ulcer treatment programme significantly improved the outcome in patients with infected diabetic foot ulcers. JPlast Reconstr Aesthet Surg 2011, 64:867-872.